#cell therapy
3 articles
Corporate Finance
Artiva Biotherapeutics faces capital shortfall risk ahead of pivotal NK cell therapy trials
ViaNews Editorial Team (Finance)•
Healthcare Finance
Biotech's Commercial Inflection: What the Gene Therapy and mRNA Pipeline Surge Means for Investors
ViaNews Editorial Team (Finance)•